Geriatric drug therapy: neglecting the inevitable majority

Sven Stegemann; Felix Ecker; Mario Maio; Peter Kraahs; Rainer Wohlfart; Joerg Breitkreutz; Andreas Zimmer; Daniel Bar-Shalom; Patrick Hettrich; Bianca Broegmann

doi:10.1016/j.arr.2010.04.005

Geriatric drug therapy: neglecting the inevitable majority

Sven Stegemann, Felix Ecker, Mario Maio, Peter Kraahs, Rainer Wohlfart, Joerg Breitkreutz, Andreas Zimmer, Daniel Bar-Shalom, Patrick Hettrich, Bianca Broegmann

105 Citations (Scopus)

Abstract

Demographic evolution will considerably increase the number of people aged 65 years and beyond in the coming decades. The elderly not only represent the most heterogeneous population, but also are a major user group for prescribed medicines, a predominance that will continue to further increase. Medicines and medication management are much more complex and challenging in the elderly and can only be addressed through a multidisciplinary approach.There is strong evidence that the elderly are able to properly manage their medication; however, their medications require different features than the standard medications used by adults. The elderly are exposed to several chronic disease conditions and their treatments, as well as experience age-related changes and limitations that need to be reflected in their medication management strategies.Geriatric drug therapy remains a multidisciplinary task. The health care industry, physicians, pharmacists, nurses and care givers provide and guide the patient's therapy according to individual needs, while the health care system and regulatory authorities build the necessary framework of support and resources.Any realistic and significant enhancement to the elderly patients' medicines and medication management needs to be addressed by all disciplines and stakeholders involved since the absence of any of the stakeholders in the overall process negatively impacts the achievable enhancement in geriatric drug therapy.

Original language	English
Journal	Ageing Research Reviews
Volume	9
Issue number	4
Pages (from-to)	384-398
ISSN	1568-1637
DOIs	https://doi.org/10.1016/j.arr.2010.04.005
Publication status	Published - Oct 2010

Keywords

Former Faculty of Pharmaceutical Sciences

Access to Document

10.1016/j.arr.2010.04.005

Cite this

@article{d2881170c58111df825b000ea68e967b,

title = "Geriatric drug therapy: neglecting the inevitable majority",

abstract = "Demographic evolution will considerably increase the number of people aged 65 years and beyond in the coming decades. The elderly not only represent the most heterogeneous population, but also are a major user group for prescribed medicines, a predominance that will continue to further increase. Medicines and medication management are much more complex and challenging in the elderly and can only be addressed through a multidisciplinary approach.There is strong evidence that the elderly are able to properly manage their medication; however, their medications require different features than the standard medications used by adults. The elderly are exposed to several chronic disease conditions and their treatments, as well as experience age-related changes and limitations that need to be reflected in their medication management strategies.Geriatric drug therapy remains a multidisciplinary task. The health care industry, physicians, pharmacists, nurses and care givers provide and guide the patient's therapy according to individual needs, while the health care system and regulatory authorities build the necessary framework of support and resources.Any realistic and significant enhancement to the elderly patients' medicines and medication management needs to be addressed by all disciplines and stakeholders involved since the absence of any of the stakeholders in the overall process negatively impacts the achievable enhancement in geriatric drug therapy.",

keywords = "Former Faculty of Pharmaceutical Sciences",

author = "Sven Stegemann and Felix Ecker and Mario Maio and Peter Kraahs and Rainer Wohlfart and Joerg Breitkreutz and Andreas Zimmer and Daniel Bar-Shalom and Patrick Hettrich and Bianca Broegmann",

year = "2010",

month = oct,

doi = "10.1016/j.arr.2010.04.005",

language = "English",

volume = "9",

pages = "384--398",

journal = "Ageing Research Reviews",

issn = "1568-1637",

publisher = "Elsevier Ireland Ltd",

number = "4",

}

TY - JOUR

T1 - Geriatric drug therapy

T2 - neglecting the inevitable majority

AU - Stegemann, Sven

AU - Ecker, Felix

AU - Maio, Mario

AU - Kraahs, Peter

AU - Wohlfart, Rainer

AU - Breitkreutz, Joerg

AU - Zimmer, Andreas

AU - Bar-Shalom, Daniel

AU - Hettrich, Patrick

AU - Broegmann, Bianca

PY - 2010/10

Y1 - 2010/10

N2 - Demographic evolution will considerably increase the number of people aged 65 years and beyond in the coming decades. The elderly not only represent the most heterogeneous population, but also are a major user group for prescribed medicines, a predominance that will continue to further increase. Medicines and medication management are much more complex and challenging in the elderly and can only be addressed through a multidisciplinary approach.There is strong evidence that the elderly are able to properly manage their medication; however, their medications require different features than the standard medications used by adults. The elderly are exposed to several chronic disease conditions and their treatments, as well as experience age-related changes and limitations that need to be reflected in their medication management strategies.Geriatric drug therapy remains a multidisciplinary task. The health care industry, physicians, pharmacists, nurses and care givers provide and guide the patient's therapy according to individual needs, while the health care system and regulatory authorities build the necessary framework of support and resources.Any realistic and significant enhancement to the elderly patients' medicines and medication management needs to be addressed by all disciplines and stakeholders involved since the absence of any of the stakeholders in the overall process negatively impacts the achievable enhancement in geriatric drug therapy.

AB - Demographic evolution will considerably increase the number of people aged 65 years and beyond in the coming decades. The elderly not only represent the most heterogeneous population, but also are a major user group for prescribed medicines, a predominance that will continue to further increase. Medicines and medication management are much more complex and challenging in the elderly and can only be addressed through a multidisciplinary approach.There is strong evidence that the elderly are able to properly manage their medication; however, their medications require different features than the standard medications used by adults. The elderly are exposed to several chronic disease conditions and their treatments, as well as experience age-related changes and limitations that need to be reflected in their medication management strategies.Geriatric drug therapy remains a multidisciplinary task. The health care industry, physicians, pharmacists, nurses and care givers provide and guide the patient's therapy according to individual needs, while the health care system and regulatory authorities build the necessary framework of support and resources.Any realistic and significant enhancement to the elderly patients' medicines and medication management needs to be addressed by all disciplines and stakeholders involved since the absence of any of the stakeholders in the overall process negatively impacts the achievable enhancement in geriatric drug therapy.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1016/j.arr.2010.04.005

DO - 10.1016/j.arr.2010.04.005

M3 - Journal article

SN - 1568-1637

VL - 9

SP - 384

EP - 398

JO - Ageing Research Reviews

JF - Ageing Research Reviews

IS - 4

ER -

Geriatric drug therapy: neglecting the inevitable majority

Abstract

Keywords

Access to Document

Fingerprint

Cite this